Skip to main content
SpringerLink
Log in

Adalimumab/infliximab

Immune thrombocytopenia and lupus-like disease: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Boiten HJ, et al. Adalimumab-induced platelet antibodies resulting in severe thrombocytopenia. British Journal of Clinical Pharmacology 87: 3619-3621, No. 9, Sep 2021. Available from: URL: http://doi.org/10.1111/bcp.14778

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab. Reactions Weekly 1885, 30 (2021). https://doi.org/10.1007/s40278-021-06789-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06789-8

Search

Navigation